S-ClassAbout S-Class
C
CMEAI Stock Diagnostic Report
CME Non-GAAP EPS of $2.99 beats by $0.08, revenue of $1.71B beats by $30M
CME Group reported second-quarter earnings per share (EPS) and revenue that exceeded market expectations, achieving the third-highest average daily trading volume (ADV) in its history.
View Source Article ↗AI CATALYST SCORE85 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
01
MARKET SNAPSHOT
Key Indicators at a Glance
Major Support230.00
Near-Term Resistance245.00
02
FUNDAMENTALS
Financial & Fundamental Analysis
CME's Non-GAAP EPS ($2.99, exceeding expectations by $0.08) and revenue ($1.71B, exceeding expectations by $30M) both recorded strong performance, and the average daily trading volume (ADV) for the second quarter of 2026 reached 29.8 million contracts, marking the third highest quarterly performance in history, demonstrating the strength of the fundamentals of its core business.
03
TECHNICAL VIEW
Technical Position & Response Criteria
The RSI is at 33.2, indicating a near oversold condition. Despite strong performance, the stock is showing a downward trend on the day, making it advantageous to approach after confirming support around the $230 level.
Support230.00
Resistance245.00
04
CATALYST & STRATEGY
Catalyst Analysis & Forward Strategy
In the second quarter of 2026, the daily average trading volume (ADV) reached 29.8 million contracts, marking the third highest on record and driving revenue and EPS surprises.
05
PROOF OF WORK
Analysis Point vs. Subsequent Price Action
INITIAL · At Analysis (2026-07-22)
FINAL · Current/Verified
Renders the actual stored OHLC data directly in your browser.